ALIMERA SCIENCES, INC. WARRANT TO PURCHASE SHARES OF SERIES A PREFERRED STOCKWarrant Agreement • October 2nd, 2012 • Alimera Sciences Inc • Pharmaceutical preparations • Delaware
Contract Type FiledOctober 2nd, 2012 Company Industry JurisdictionPursuant to the terms of that certain Securities Purchase Agreement (as may be amended or restated from time to time, the “Purchase Agreement”) dated as of July 17, 2012, among Alimera Sciences, Inc., a Delaware corporation (the “Company”), the Holder (as defined below) and certain other investors, for consideration, the receipt and sufficiency of which is hereby acknowledged, this Warrant (this “Warrant”) is issued to Palo Alto Healthcare Master Fund II, L.P., a Cayman Islands limited partnership, or its assigns (the “Holder”) by the Company. Capitalized terms not defined herein shall have the meanings set forth in the Purchase Agreement.
ALIMERA SCIENCES, INC. WARRANT TO PURCHASE SHARES OF SERIES A PREFERRED STOCKWarrant Agreement • October 2nd, 2012 • Alimera Sciences Inc • Pharmaceutical preparations • Delaware
Contract Type FiledOctober 2nd, 2012 Company Industry JurisdictionPursuant to the terms of that certain Securities Purchase Agreement (as may be amended or restated from time to time, the “Purchase Agreement”) dated as of July 17, 2012, among Alimera Sciences, Inc., a Delaware corporation (the “Company”), the Holder (as defined below) and certain other investors, for consideration, the receipt and sufficiency of which is hereby acknowledged, this Warrant (this “Warrant”) is issued to Micro Cap Partners, L.P., a Delaware limited partnership, or its assigns (the “Holder”) by the Company. Capitalized terms not defined herein shall have the meanings set forth in the Purchase Agreement.
ALIMERA SCIENCES, INC. WARRANT TO PURCHASE SHARES OF SERIES A PREFERRED STOCKWarrant Agreement • October 2nd, 2012 • Alimera Sciences Inc • Pharmaceutical preparations • Delaware
Contract Type FiledOctober 2nd, 2012 Company Industry JurisdictionPursuant to the terms of that certain Securities Purchase Agreement (as may be amended or restated from time to time, the “Purchase Agreement”) dated as of July 17, 2012, among Alimera Sciences, Inc., a Delaware corporation (the “Company”), the Holder (as defined below) and certain other investors, for consideration, the receipt and sufficiency of which is hereby acknowledged, this Warrant (this “Warrant”) is issued to Palo Alto Healthcare Master Fund, L.P., a Cayman Islands limited partnership, or its assigns (the “Holder”) by the Company. Capitalized terms not defined herein shall have the meanings set forth in the Purchase Agreement.
ALIMERA SCIENCES, INC. WARRANT TO PURCHASE SHARES OF SERIES A PREFERRED STOCKWarrant Agreement • October 2nd, 2012 • Alimera Sciences Inc • Pharmaceutical preparations • Delaware
Contract Type FiledOctober 2nd, 2012 Company Industry JurisdictionPursuant to the terms of that certain Securities Purchase Agreement (as may be amended or restated from time to time, the “Purchase Agreement”) dated as of July 17, 2012, among Alimera Sciences, Inc., a Delaware corporation (the “Company”), the Holder (as defined below) and certain other investors, for consideration, the receipt and sufficiency of which is hereby acknowledged, this Warrant (this “Warrant”) is issued to Sofinnova Venture Partners VIII, L.P., a Delaware limited partnership, or its assigns (the “Holder”) by the Company. Capitalized terms not defined herein shall have the meanings set forth in the Purchase Agreement.
ALIMERA SCIENCES, INC. WARRANT TO PURCHASE SHARES OF SERIES A PREFERRED STOCKWarrant Agreement • October 2nd, 2012 • Alimera Sciences Inc • Pharmaceutical preparations • Delaware
Contract Type FiledOctober 2nd, 2012 Company Industry JurisdictionPursuant to the terms of that certain Securities Purchase Agreement (as may be amended or restated from time to time, the “Purchase Agreement”) dated as of July 17, 2012, among Alimera Sciences, Inc., a Delaware corporation (the “Company”), the Holder (as defined below) and certain other investors, for consideration, the receipt and sufficiency of which is hereby acknowledged, this Warrant (this “Warrant”) is issued to Growth Equity Opportunities Fund III, LLC, a Delaware limited liability company, or its assigns (the “Holder”) by the Company. Capitalized terms not defined herein shall have the meanings set forth in the Purchase Agreement.
ALIMERA SCIENCES, INC. WARRANT TO PURCHASE SHARES OF SERIES A PREFERRED STOCKWarrant Agreement • July 18th, 2012 • Alimera Sciences Inc • Pharmaceutical preparations • Delaware
Contract Type FiledJuly 18th, 2012 Company Industry JurisdictionPursuant to the terms of that certain Securities Purchase Agreement (as may be amended or restated from time to time, the “Purchase Agreement”) dated as of July , 2012, among Alimera Sciences, Inc., a Delaware corporation (the “Company”), the Holder (as defined below) and certain other investors, for consideration, the receipt and sufficiency of which is hereby acknowledged, this Warrant (this “Warrant”) is issued to Palo Alto Investors, LLC, a California limited liability company, or its assigns (the “Holder”) by the Company. Capitalized terms not defined herein shall have the meanings set forth in the Purchase Agreement.